Nicotinic receptor subtypes and cognitive function

Journal of Neurobiology

Volumn 53, Issue 4, 2002, Pages 633-640

  Levin, Edward D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

4 2 receptors; 7 receptors; Amygdala; Hippocampus; Nicotine; Nicotinic; Radial arm maze; Working memory

Indexed keywords

MECAMYLAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; ATTENTION DEFICIT DISORDER; COGNITIVE DEFECT; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; HUMAN; HYPOTHALAMUS; MAZE TEST; MEMORY DISORDER; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; TASK PERFORMANCE; WORKING MEMORY;

AMYGDALA; ANIMALS; COGNITION; HIPPOCAMPUS; HUMANS; MEMORY; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RECEPTORS, NICOTINIC;

EID: 0036890828     PISSN: 00223034     EISSN: None     Source Type: Journal    
DOI: 10.1002/neu.10151     Document Type: Article

References (57)

1. Addy N, Nakajama A, Levin E. 2002. Nicotinic mechanisms of memory: Effects of acute local DHbE and MLA infusions in the basolateral amygdala. Cognit Brain Res, in press.
2. Alkondon M, Albuquerque EX. 2001. Nicotinic acetylcholine receptor alpha7 and alpha4beta2 subtypes differentially control GABAergic input to CA1 neurons in the rat hippocampus. J Neurophysiol 86:3043-3055.
3. Arendash GW, Sengstock GJ, Sanberg PR, Kem WR. 1995. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res 674:252-259.
4. Bancroft A, Levin ED. 2000. Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory. Neuropharmacology 39:2770-2778.
5. Bettany JH, Levin ED. 2001. Ventral hippocampal alpha7 nicotinic receptors and chronic nicotine effects on memory. Pharmacol Biochem Behav 70:467-474.
6. Brioni JD, Decker MW, Sullivan JP, Arneric SP. 1997. The pharmacology of (-)-nicotine and novel cholinergic channel modulators. Adv Pharmacol 37:153-214.
7. Broide RS, Leslie FM. 1999. The alpha7 nicotinic acetylcholine receptor in neuronal plasticity. Mol Neurobiol 20:1-16.
8. Buccafusco JJ, Jackson WJ, Terry AV, Marsh KC, Decker MW, Arneric SP. 1995. Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: A novel cholinergic channel activator for memory enhancement. Psychopharmacology (Berlin) 120:256-266.
9. Buccafusco JJ, Prendergast MA, Terry AV, Jackson WJ. 1996. Cognitive effects of nicotinic cholinergic receptor agonists in nonhuman primates. Drug Dev Res 38:196-203.
10. Decker MW, Curzon P, Brioni JD, Arneric SP. 1994. Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats. Eur J Pharmacol 261:217-222.
11. Didier M, Bix G, Berman SA, Bursztajn S. 1995. Expression of the alpha 4 neuronal nicotinic acetylcholine receptor subunit in the developing mouse hippocampus. Int J Dev Neurosci 13:705-713.
12. Durany N, Zochling R, Boissl KW, Paulus W, Ransmayr G, Tatschner T, Danielczyk W, Jellinger K, Deckert J, Riederer P. 2000. Human post-mortem striatal alpha4beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome. Neurosci Lett 287:109-112.
13. Fabian-Fine R, Skehel P, Errington ML, Davies HA, Sher E, Stewart MG, Fine A. 2001. Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J Neurosci 21:7993-8003.
14. Felix R, Levin ED. 1997. Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats. Neuroscience 81:1009-1017.
15. Giacobini E, DeSarno P, Clark B, McIlhany M. 1989. The cholinergic receptor system of the human brain. Neurochemical and pharmacological aspects of aging and Alzheimer. In: Nordberg A, editor. Progress in Brain Research. Amsterdam: Elsevier, p 335-343.
16. Kellar KJ, Wonnacott S. 1990. Nicotinic cholinergic receptors in Alzheimer's disease. In: Wonnacott S, Russell MAH, Stolerman IP, editors. Nicotine Psychopharmacology: Molecular, Cellular, and Behavioral Aspects. Oxford: Oxford University Press, p 341-373.
17. Kim J, Levin E. 1996. Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: Effects on spatial working memory in rats. Brain Res 725:231-240.
18. Leonard S, Breese C, Adams C, Benhammou K, Gault J, Stevens K, Lee M, Adler L, Olincy A, Ross R, Freedman R. 2000. Smoking and schizophrenia: Abnormal nicotinic receptor expression. Eur J Pharmacol 393:237-242.
19. Levin E, Christopher N. 2002. Persistence of nicotinic agonist RJR 2403 induced working memory improvement in rats. Drug Dev Res 55:97-103.
20. Levin E, Kaplan S, Boardman A. 1997. Acute nicotine interactions with nicotinic and muscarinic antagonists: Working and reference memory effects in the 16-arm radial maze. Behav Pharmacol 8:236-242.
21. Levin E, Kim P, Meray R. 1996a. Chronic nicotine effects on working and reference memory in the 16-arm radial maze: Interactions with D1 agonist and antagonist drugs. Psychopharmacology (Berlin) 127:25-30.
22. Levin E, Wilson W, Rose J, McEvoy J. 1996b. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15:429-436.
23. Levin ED, Rose JE. 1990. Anticholinergic sensitivity following chronic nicotine administration as measured by radial-arm maze performance in rats. Behav Pharmacol 1:511-520.
24. Levin ED, Rose JE. 1995. Acute and chronic nicotinic interactions with dopamine systems and working memory performance. In: Lajtha A, Abood L, editors. Functional Diversity of Interacting Receptors. New York: The New York Academy of Sciences, p 218-221.
25. Levin ED, Simon BB. 1998. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berlin) 138:217-230.
26. Levin ED, Slotkin TA. 1998. Developmental neurotoxicity of nicotine. In: W. Slikker W Jr, Chang LW, editors. Handbook of Developmental Neurotoxicology. San Diego: Academic Press, p 587-615.
27. Levin ED, Torry D. 1996. Acute and chronic nicotine effects on working memory in aged rats. Psychopharmacology (Berlin) 123:88-97.
28. Levin ED, Bettegowda C, Blosser J, Gordon J. 1999a. AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats. Behav Pharmacol 10:675-680.
29. Levin ED, Bettegowda C, Weaver T, Christopher NC. 1998. Nicotine-dizocilpine interactions and working and reference memory performance of rats in the radial-arm maze. Pharmacol Biochem Behav 61:335-340.
30. Levin ED, Bradley A, Addy N, Sigurani N. 2002. Hippocampal α7 and α4β2 nicotinic receptors and working memory. Neuroscience 109:757-765.
31. Levin ED, Briggs SJ, Christopher NC, Auman JT. 1994. Working memory performance and cholinergic effects in the ventral tegmental area and substantia nigra. Brain Res 657:165-170.
32. Levin ED, Briggs SJ, Christopher NC, Rose JE. 1993a. Chronic nicotinic stimulation and blockade effects on working memory. Behav Pharmacol 4:179-182.
33. Levin ED, Christopher NC, Briggs SJ, Auman JT. 1996c. Chronic nicotine-induced improvement of spatial working memory and D2 dopamine effects in rats. Drug Dev Res 39:29-35.
34. Levin ED, Christopher NC, Briggs SJ, Rose JE. 1993b. Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. Cognit Brain Res 1:137-143.
35. Levin ED, Christopher NC, Weaver T, Moore J, Brucato F. 1999b. Ventral hippocampal ibotenic acid lesions block chronic nicotine-induced spatial working memory improvement in rats. Cognit Brain Res 7:405-410.
36. Levin ED, Conners CK, Sparrow E, Hinton S, Meck W, Rose JE, Ernhardt D, March J. 1996d. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berlin) 123:55-63.
37. Levin ED, Lee C, Rose JE, Reyes A, Ellison G, Jarvik M, Gritz E. 1990. Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. Behav Neural Biol 53:269-276.
38. London ED, Ball MJ, Waller SB. 1989. Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's disease. Neurochem Res 14:745-750.
39. Maren S. 1999. Neurotoxic basolateral amygdala lesions impair learning and memory but not the performance of conditional fear in rats. J Neurosci 19:8696-8703.
40. Martin-Ruiz CM, Court JA, Molnar E, Lee M, Gotti C, Mamalaki A, Tsouloufis T, Tzartos S, Ballard C, Perry RH, Perry EK. 1999. Alpha 4 but not alpha 3 and alpha 7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J Neurochem 73:1635-1640.
41. McGaughy J, Decker MW, Sarter M. 1999. Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats. Psychopharmacology (Berlin) 144:175-182.
42. Meyer EM, de Fiebre CM, Hunter BE, Simpkins CE, Frauworth N, de Fiebre NE. 1994. Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev. Res. 31:127-134.
43. Meyer EM, Tay ET, Papke RL, Meyers C, Huang GL, deFiebre CM. 1997. 3-[2,4-Dimethoxybenzylidene]-anabaseine (DMXB) selectively activates rat alpha 7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner. Brain Res 768:49-56.
44. Mirza NR, Stolerman IP. 1998. Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharmacology (Berlin) 138:266-274.
45. Newhouse PA, Potter A, Levin ED. 1997. Nicotinic system involvement in Alzheimer's and Parkinson's diseases: Implications for therapeutics. Drug Aging 11:206-228.
46. 3H-acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett 72:115-119.
47. Ohno M, Frankland PW, Chen AP, Costa RM, Silva AJ. 2001. Inducible, pharmacogenetic approaches to the study of learning and memory. Nat Neurosci 4:1238-1243.
48. Ohno M, Yamamoto T, Watanabe S. 1993. Blockade of hippocampal nicotinic receptors impairs working memory but not reference memory in rats. Pharmacol Biochem Behav 45:89-93.
49. Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, Mckeith IG, Irving D, Brown A, Perry RH. 1995. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology. Neuroscience 64:385-395.
50. Rinne JO, Myllykylä T, Lönnberg P, Marjamäki P. 1991. A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease. Brain Res 547:167-170.
51. Rusted JM, Newhouse PA, Levin ED. 2000. Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer's disease and Parkinson's disease. Behav Brain Res 113:121-129.
52. Shimohama S, Taniguchi T, Fujiwara M, Kameyama M. 1986. Changes in nicotinic and muscarinic receptors in Alzheimer-type dementia. J Neurochem 46:288-293.
53. Stolerman IP, Mirza NR, Hahn B, Shoaib M. 2000. Nicotine in an animal model of attention. Eur J Pharmacol 393:147-154.
54. White HK, Levin ED. 1999. Chronic four week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology (Berlin) 143:158-165.
55. Whiteaker P, Davies ARL, Marks MJ, Blagbrough IS, Potter BVL, Wolsten-Holme AJ, Collins AC, Wonnacott S. 1999. An autoradiographic study of the distribution of binding sites for the novel alpha 7-selective nicotinic radioligand. Eur J Neurosci 11:2689-2696.
56. 3H]ni-cotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: An autoradiographic study. Neurology 38:720-723.
57. Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, McFalls E, Kovera C, McCarten JR. 1995. Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety. Pharmacol Biochem Behav 51:509-514.